Diagnosis requires a combination of clinical performance, imaging, laboratory testing, and pathology. The platform can assist in linking a team of authoritative experts at home and abroad to provide accurate diagnostics and treatment plans. Individualised treatment plans for treatment and management of hematoma B are often developed, including multiple-dimensional management such as drug therapy, rehabilitation, and regular follow-up.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult-to-treat blood tumour diseases have been significantly improved. Treatment requires close monitoring of efficacy and adverse reactions and timely adjustment according to changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of hematopoietic disease B.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.